Zacks: Analysts Set $25.50 Price Target for CRISPR THERAPTC (CRSP) – Sports Perspectives
|
Zacks: Analysts Set $25.50 Price Target for CRISPR THERAPTC (CRSP)
Sports Perspectives CRISPR THERAPTC logo CRISPR THERAPTC (NASDAQ:CRSP) has been assigned an average broker rating score of 1.00 (Strong Buy) from the two analysts that cover the stock, Zacks Investment Research reports. Two research analysts have rated the … |
